Ambrosia Biosciences

Boulder, United States

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

Mar 2026

Series B

Biopharma Biotechnology Health Care

Top Investors

Janus Henderson InvestorsSamsara BioCapitalBlue OwlRedmile GroupMerck

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ambrosia Biosciences

Who are Ambrosia Biosciences's investors?

Ambrosia Biosciences's investors include Janus Henderson Investors, Samsara BioCapital, Blue Owl, Redmile Group, Merck.

Where is Ambrosia Biosciences headquartered?

Ambrosia Biosciences is headquartered in Boulder, United States.

What does Ambrosia Biosciences do?

Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.

What stage is Ambrosia Biosciences at?

Ambrosia Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 31, 2026.

MLA

"Ambrosia Biosciences — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/ambrosia-biosciences. Accessed July 1, 2026.

APA

VCBacked. (2026). Ambrosia Biosciences — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ambrosia-biosciences

Wikipedia (cite web)

{{cite web |title=Ambrosia Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/ambrosia-biosciences |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 31, 2026.

Similar Companies in Biopharma

View all

Living In Silico Inc.

Crystalys Therapeutics

San Diego

ARS Pharmaceuticals

San Diego